SCHEMBL3074599

SCHEMBL3074599

CC=NNc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 2/20 0.58
MAPT P10636 8/20 0.48
GAA P10253 6/20 0.48
MEN1 O00255 6/20 0.48
KMT2A Q03164 6/20 0.48
ALDH1A1 P00352 6/20 0.48
HPGD P15428 3/20 0.48
RAB9A P51151 3/20 0.48
LMNA P02545 2/20 0.48
GFER P55789 2/20 0.48
TDP1 Q9NUW8 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPK1 P28482 1/20 0.43
TSHR P16473 2/20 0.43
CYP1A1 P04798 1/20 0.43
CYP1B1 Q16678 1/20 0.43
SENP7 Q9BQF6 2/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1005100 1.00 NOX1 (0.58) NOX1MAPTGAAMEN1KMT2A
SCHEMBL3074596 1.00 NOX1 (0.58) NOX1MAPTGAAMEN1KMT2A
SCHEMBL11831353 0.98 NOX1 (0.56) NOX1MAPTGAAMEN1KMT2A
SCHEMBL11831344 0.98 NOX1 (0.56) NOX1MAPTGAAMEN1KMT2A
SCHEMBL16111932 0.79 NOX1 (0.62) NOX1MAPTGAAMEN1KMT2A
SCHEMBL16111930 0.79 NOX1 (0.62) NOX1MAPTGAAMEN1KMT2A
SCHEMBL13109406 0.79 NOX1 (0.62) NOX1MAPTGAAMEN1KMT2A
SCHEMBL765856 0.78 GAA (0.52) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL14438098 0.76 MAPT (0.50) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL1002645 0.76 NOX1 (0.34) NOX1MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106701733-A Modified zeolite functional material for fixing benzene degrading bacteria and preparation method thereof 光合强化(北京)生物科技有限公司 2017-05-24 CN claimed
US-20150374694-A1 TGF-BETA ENHANCING COMPOSITIONS FOR CARTILAGE REPAIR AND METHODS RELATED THERETO THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2015-12-31 US claimed
WO-2014130411-A9 TGF-BETA ENHANCING COMPOSITIONS FOR CARTILAGE REPAIR AND METHODS RELATED THERETO EMORY UNIVERSITY (US) 2014-10-16 WO claimed
WO-2014130411-A1 TGF-BETA ENHANCING COMPOSITIONS FOR CARTILAGE REPAIR AND METHODS RELATED THERETO EMORY UNIVERSITY (US) 2014-08-28 WO claimed
US-4410457-A EPOXY REACTIVE SOLVENT, EPOXY RESIN, LATENT HARDENER, EPOXIDE-DIALKYLAMINE ADDUCT SUMITOMO CHEMICAL CO., LTD. (JP) 1983-10-18 US claimed
US-20260009142-A1 Electrochemical synthesis of pyrazolines and pyrazoles BAYER AG (DE) 2026-01-08 US disclosed
EP-4555128-A1 ELECTROCHEMICAL SYNTHESIS OF PYRAZOLINES AND PYRAZOLES Bayer Aktiengesellschaft (DE) 2025-05-21 EP disclosed
CN-119698496-A Electrochemical synthesis of pyrazolines and pyrazoles 拜耳公司 2025-03-25 CN disclosed
WO-2025003282-A2 ATP PRODUCTION FROM ELECTRICITY WITH A NEW-TO-NATURE ELECTROBIOLOGICAL MODULE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-01-02 WO disclosed
EP-4484566-A1 ATP PRODUCTION FROM ELECTRICITY WITH A NEW-TO-NATURE ELECTROBIOLOGICAL MODULE Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-01-01 EP disclosed
CN-114315726-B Preparation method of gem-difluoroallyl compound 中国科学院上海有机化学研究所 2024-02-09 CN disclosed
WO-2024012791-A1 ELECTROCHEMICAL SYNTHESIS OF PYRAZOLINES AND PYRAZOLES BAYER AKTIENGESELLSCHAFT (DE) 2024-01-18 WO disclosed
US-4725628-A Process of making a crosslinked superabsorbent polyurethane foam KIMBERLY-CLARK CORPORATION (US) 1988-02-16 US disclosed
US-4710559-A Heat curable organopolysiloxane compositions WACKER SILICONES CORPORATION (US) 1987-12-01 US disclosed
EP-0039230-B1 CURABLE COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-12-11 EP disclosed
US-4410457-A EPOXY REACTIVE SOLVENT, EPOXY RESIN, LATENT HARDENER, EPOXIDE-DIALKYLAMINE ADDUCT SUMITOMO CHEMICAL CO., LTD. (JP) 1983-10-18 US disclosed
US-4360649-A EPOXY RESIN, EPOXIDE-DIALKYLAMINE ADDUCT, UREA COMPOUND, CURING AGENTS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-11-23 US disclosed
EP-0039230-A2 Curable composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-11-04 EP disclosed
US-4172835-A URINARY ANTISEPTIC, HYPOTENSIVE AGENT AND HYPOGLYCEMIC AGENT STERLING DRUG INC. (US) 1979-10-30 US disclosed
US-3948939-A 9-Acyl-1,2,3,4-tetrahydrocarbazole-3 and 4-carboxylic acids STERLING DRUG INC. (US) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150374694-A1 TGF-BETA ENHANCING COMPOSITIONS FOR CARTILAGE REPAIR AND METHODS RELATED THERETO COL2A1, TGFB1, TGFBR1 NOX1 1122/4885MAPT 4307/4885GAA 1666/4885
US-20260009142-A1 Electrochemical synthesis of pyrazolines and pyrazoles CYP2E1, CYP2F1, CYP4F2 NOX1 280/4885MAPT 4836/4885GAA 3100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.